
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
miR-16-5p and miR-19b-3p prevent amyloid β-induced injury by targeting BACE1 in SH-SY5Y cells
Nan Zhang, Weiwei Li, Chunmei Lv, et al.
Neuroreport (2019) Vol. 31, Iss. 3, pp. 205-212
Closed Access | Times Cited: 39
Nan Zhang, Weiwei Li, Chunmei Lv, et al.
Neuroreport (2019) Vol. 31, Iss. 3, pp. 205-212
Closed Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 88
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 88
Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1219-1219
Open Access | Times Cited: 51
Ma’mon M. Hatmal, Mohammad A. I. Al-Hatamleh, Amin N. Olaimat, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1219-1219
Open Access | Times Cited: 51
Exploiting machine learning models to identify novel Alzheimer’s disease biomarkers and potential targets
Hind Alamro, Maha A. Thafar, Somayah Albaradei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Hind Alamro, Maha A. Thafar, Somayah Albaradei, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 34
Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p
Jingjing Zhang, Rui Wang
Experimental Gerontology (2020) Vol. 144, pp. 111180-111180
Closed Access | Times Cited: 58
Jingjing Zhang, Rui Wang
Experimental Gerontology (2020) Vol. 144, pp. 111180-111180
Closed Access | Times Cited: 58
Brain cell-derived exosomes in plasma serve as neurodegeneration biomarkers in male cynomolgus monkeys self-administrating oxycodone
Ashish Kumar, Susy Kim, Yixin Su, et al.
EBioMedicine (2021) Vol. 63, pp. 103192-103192
Open Access | Times Cited: 54
Ashish Kumar, Susy Kim, Yixin Su, et al.
EBioMedicine (2021) Vol. 63, pp. 103192-103192
Open Access | Times Cited: 54
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 19
Long Wang, Xindong Shui, Yuelin Diao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16259-16259
Open Access | Times Cited: 19
A new perspective on Alzheimer’s disease: microRNAs and circular RNAs
Shahidee Zainal Abidin, Nurul Asykin Mat Pauzi, Nur Izzati Mansor, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 18
Shahidee Zainal Abidin, Nurul Asykin Mat Pauzi, Nur Izzati Mansor, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 18
Molecular mechanisms implicated in protein changes in the Alzheimer’s disease human hippocampus
Hai Duc Nguyen, Woong-Ki Kim, Giang Huong Vu
Mechanisms of Ageing and Development (2024) Vol. 219, pp. 111930-111930
Open Access | Times Cited: 5
Hai Duc Nguyen, Woong-Ki Kim, Giang Huong Vu
Mechanisms of Ageing and Development (2024) Vol. 219, pp. 111930-111930
Open Access | Times Cited: 5
Biomarkers in Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Regulation of Apoptotic Pathways by MicroRNAs: A Therapeutic Strategy for Alzheimer’s Disease
Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi, et al.
Molecular Neurobiology (2025)
Closed Access
Mohamed J. Saadh, Faris Anad Muhammad, Tuqa S. Alazzawi, et al.
Molecular Neurobiology (2025)
Closed Access
MicroRNAs in tear fluids predict underlying molecular changes associated with Alzheimer’s disease
Printha Wijesinghe, Jeanne Xi, Jing Cui, et al.
Life Science Alliance (2023) Vol. 6, Iss. 6, pp. e202201757-e202201757
Open Access | Times Cited: 12
Printha Wijesinghe, Jeanne Xi, Jing Cui, et al.
Life Science Alliance (2023) Vol. 6, Iss. 6, pp. e202201757-e202201757
Open Access | Times Cited: 12
Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
Weimin Qiu, Hui Liu, Yijun Liu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1091-1140
Open Access | Times Cited: 12
Weimin Qiu, Hui Liu, Yijun Liu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 4, pp. 1091-1140
Open Access | Times Cited: 12
Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
Ahmed Noor Eddin, Khaled Hamsho, Ghaith Adi, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Ahmed Noor Eddin, Khaled Hamsho, Ghaith Adi, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 12
Unlocking the Therapeutic Promise of miRNAs in Promoting Amyloid-β Clearance for Alzheimer's Disease.
Vajinder Kaur, Aditya Sunkaria
Behavioural Brain Research (2025), pp. 115505-115505
Closed Access
Vajinder Kaur, Aditya Sunkaria
Behavioural Brain Research (2025), pp. 115505-115505
Closed Access
Deciphering the roles of miR-16-5p in malignant solid tumors
Liuyi Yang, Sen Yang, Congcong Ren, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112703-112703
Open Access | Times Cited: 16
Liuyi Yang, Sen Yang, Congcong Ren, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112703-112703
Open Access | Times Cited: 16
NcRNAs: A synergistically antiapoptosis therapeutic tool in Alzheimer's disease
Liangxian Li, Mingyue Jin, Jie Tan, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 9
Liangxian Li, Mingyue Jin, Jie Tan, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 4
Open Access | Times Cited: 9
Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice
Melina Rojas, Nil Novau-Ferré, Laia Gutiérrez-Tordera, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 955-955
Open Access | Times Cited: 3
Melina Rojas, Nil Novau-Ferré, Laia Gutiérrez-Tordera, et al.
Nutrients (2024) Vol. 16, Iss. 7, pp. 955-955
Open Access | Times Cited: 3
Exosomal MicroRNAs in Alzheimer’s Disease: Unveiling Their Role and Pioneering Tools for Diagnosis and Treatment
Alhanof Alhenaky, Safiah Alhazmi, Sultan H. Alamri, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6960-6960
Open Access | Times Cited: 3
Alhanof Alhenaky, Safiah Alhazmi, Sultan H. Alamri, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 22, pp. 6960-6960
Open Access | Times Cited: 3
Is It the Twilight of BACE1 Inhibitors?
Martina Hrabinová, Jaroslav Pejchal, Tomáš Kučera, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 1, pp. 61-77
Open Access | Times Cited: 21
Martina Hrabinová, Jaroslav Pejchal, Tomáš Kučera, et al.
Current Neuropharmacology (2020) Vol. 19, Iss. 1, pp. 61-77
Open Access | Times Cited: 21
RETRACTED: MicroRNA-16-5p/BTG2 axis affects neurological function, autophagy and apoptosis of hippocampal neurons in Alzheimer's disease
Lixia Dong, Hai-Lan Bao, Yanyun Zhang, et al.
Brain Research Bulletin (2021) Vol. 175, pp. 254-262
Closed Access | Times Cited: 13
Lixia Dong, Hai-Lan Bao, Yanyun Zhang, et al.
Brain Research Bulletin (2021) Vol. 175, pp. 254-262
Closed Access | Times Cited: 13
CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing
Yongping Li, Tobias Fehlmann, Adam Borcherding, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. 2, pp. e10-e10
Open Access | Times Cited: 14
Yongping Li, Tobias Fehlmann, Adam Borcherding, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. 2, pp. e10-e10
Open Access | Times Cited: 14
Long noncoding RNA KCNQ1OT1 aggravates cerebral infarction by regulating PTBT1/SIRT1 via miR-16-5p
Yuanming Jiang, Chi Ma, Yuxiu Guan, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 4, pp. 276-288
Closed Access | Times Cited: 1
Yuanming Jiang, Chi Ma, Yuxiu Guan, et al.
Journal of Neuropathology & Experimental Neurology (2024) Vol. 83, Iss. 4, pp. 276-288
Closed Access | Times Cited: 1
Genotype Characterization and MiRNA Expression Profiling in Usher Syndrome Cell Lines
Wesley A. Tom, Dinesh S. Chandel, Chao Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9993-9993
Open Access | Times Cited: 1
Wesley A. Tom, Dinesh S. Chandel, Chao Jiang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9993-9993
Open Access | Times Cited: 1
RETRACTED: LncRNA NEAT1 inhibition upregulates miR-16-5p to restrain the progression of sepsis-induced lung injury via suppressing BRD4 in a mouse model
Jianhong Yin, Bin Han, Yuan Shen
International Immunopharmacology (2021) Vol. 97, pp. 107691-107691
Closed Access | Times Cited: 10
Jianhong Yin, Bin Han, Yuan Shen
International Immunopharmacology (2021) Vol. 97, pp. 107691-107691
Closed Access | Times Cited: 10
Common Molecular Signatures Between Coronavirus Infection and Alzheimer’s Disease Reveal Targets for Drug Development
Morteza Abyadeh, Vijay K. Yadav, Alaattin Kaya
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 3, pp. 995-1011
Open Access | Times Cited: 3
Morteza Abyadeh, Vijay K. Yadav, Alaattin Kaya
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 3, pp. 995-1011
Open Access | Times Cited: 3